Demystifying Cord Blood: Answers to Common Questions from Cell Therapy Developers
Allogeneic cell and gene therapy developers considering cord blood as the source material for their therapy recognize the advantages it holds—from its naïve state to being cryopreserved and readily available. However, developers often have questions for ... Continued
